3 ms·
From what I gathered, the fatality rate came from papers like [1]. These are case fatality rates (CFR) derived from the number of people presenting at clinics w
by oldgradstudent 4y ago
From what I gathered, the fatality rate came from papers like [1]. These are case fatality rates (CFR) derived from the number of people presenting at clinics with symptoms severe enough.
It cannot be compare to fatality rates of Covid where everyone who gets a positive antigen test, regardless of the severity of symptoms, or even existence of symptoms is part of the denominator.
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870502/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870502/
- sudosysgen 4y agoNot quite. Clusters of monkeypox have been studied, where the number of exposed people was known and they were traced, therefore clinical presentation was not a significant confounding factor: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC120683/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC120683/ Of course the sample size is limited, but they seemed consistent with other mortality data. Also, unlike in COVID, asymptomatic infection has never been demonstrated.
- oldgradstudent 4y agoRecent Israeli Ministry of Health presentation claims that many infections are asymptomatic as demonstrated by serological studies. https://youtu.be/U7LgEHujoTU?t=710 https://youtu.be/U7LgEHujoTU?t=710 (sorry for the Hebrew link) If this is true, the 3% of 10% mortality rates are massively inflated.
- oldgradstudent 4y agoI am not sure we can deduce that from the paper. They are only testing clearly symptomatic patients. This cannot demonstrate asymptomatic infection if it exists. Tracing also cannot demonstrate asymptomatic infection. It may be able to demonstrate asymptomatic transmission, though. Today we define a Covid-19 case extremely liberally, which results in very low fatality rates. This is not comparable to the methods used for monkeypox in the early 2000s.